PreB1 (CD10^-) Acute Lymphoblastic Leukemia: Immunophenotypic and Genomic Characteristics, Clinical Features and Outcome in 38 Adults and 26 Children

References

• Anderson K. C., Bates M. P., Slaughenhoupt B. L., Pinkus G. S., Schlossman S. F., Nadler L. M. Expression of human B-cell-associated antigens on leukaemias and lymphomas: model of human B cell differentiation. Blood 1984; 63: 1424–1433
   PubMed Web of Science ®Google Scholar
• Foon K. A., Tood R. F. Immunologic classification of leukemia and lymphoma. Blood 1986; 68: 1–31
   PubMed Web of Science ®Google Scholar
• Ludwig W. D., Reiter A., Löffler H., Gökbuget Hoelzer D., Riehm H., Thiel E. Immunophenotypic features of childhood an adult acute lymphoblastic leukemia (ALL): Experience of German Multicentre Trials ALL-BFM and GMALL. Leukemia and Lymphoma 1994; 13: 71–76
   PubMed Web of Science ®Google Scholar
• Garand R., Béné M. C., the GEIL. A new approach of acute lymphoblastic leukemia immunophenotypic classification: 1984–1994 the GEIL experience. Leukemia and Lymphoma 1994; 13: 1–6
   PubMed Web of Science ®Google Scholar
• Béné M. C., Faure G., Garand R. A new approach of acute lymphoblastic leukemia (ALL) immunophenotypic classification. British Journal of Haematology 1994; 87(S1)7
   Google Scholar
• Béné M. C., Castoldi G. L., Knapp W., Ludwig W. D., Matuites E., Orfao A., van't Veer M. B. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9: 1783–1786
   PubMed Web of Science ®Google Scholar
• Chen C. S., Sorensen P. H. B., Domer P. H., Reaman G. H., Korsmeyer S. J., Heerema N. A., Hammond G. D., Kersey J. H. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated whith specific biologic variables and poor outcome. Blood 1993; 81: 2386–2393
   PubMed Web of Science ®Google Scholar
• Pui C. H., Williams D. L., Raimondi S. C., Melvin S. L., Behm F. G., Look A. T., Dahl G. V., Rivera G. K., Kalwinsky D. K., Mirro J., Dodge R. K., Murphy S. B. Unfavorable presenting clinical and laboratory features are associated with calla- negative non-T, non-B lymphoblastic leukemia in children. Leukemia Research 1986; 10: 1287–1292
   PubMed Web of Science ®Google Scholar
• Vannier J. P., Béné M. C., Faure G., Bastard C., Garand R., Bernard A. Investigation of CD 10 (cALLA) negative acute lymphoblastic leukemia: further description of a group with a poor prognosis. British Journal of Haematology 1989; 72: 156–160
   PubMed Web of Science ®Google Scholar
• Crist W. M., Cleary M. L., Grossi C. E., Prasthofer E. F., Heggie G. D., Omura G. A., Carroll A. J., Link M. P., Sklar J. Acute leukemias associated with the 4 11 chromosome translocation have rearranged immunoglobulin heavy chain genes. Blood 1985; 66: 33–38
   PubMed Web of Science ®Google Scholar
• Ludwig W. D., Bartram C. R., Ritter J., Raghavachar A., Hiddemann W., Hiel G., Harbott J., Seibt-Jung H., Teichmann J. V., Riehm H. Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis. Blood 1988; 71: 1518–1528
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Gallon D. A. G., Gralnick M. R., Sultan C., The FAB Cooperative Group. The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlation. British Journal of Haematology 1981; 47: 553–561
   PubMed Web of Science ®Google Scholar
• Schaison G., Leverger G., Bancillon A., Marty M., Olive D., Cornu G., Griscelli C., Lemerle S., Harrousseau J. L., Bonnet M., Freycon F., Dufillot D., Demeocq F., Bauters F., Lamagnere J. P., Taboureau O. Intermediate risk childhood acute lymphoblastic leukemias: ansacrine + cytosine arabinoside versus intermediate dose methotrexate + vincristine monthly pulses for maintenance. Hämatologie und Bluttransfusion 1987; 30: 461–465
   Google Scholar
• Maurus R., Boilletot A., Otten J., Philippe N., Bensit Y., Behar C., Casteels-van Daele M., Chantraine J. M., Delbecke M. J., Gyselinck J., Hainaut H., Lutz P., Plouvier E., Robert A., Sauveur E., Solbu G., Souillet G., Sucui E., (EORTC Children's Leukemia Cooperative Group). Treatment of acute lymphoblastic leukemia in children with the BFM protocol: a cooperative study and analysis of prognostic factors. Hämatologie und Blut-transfusion 1987; 30: 466–470
   PubMedGoogle Scholar
• Fière D., Venant J. F., Attal M., Degos L., Reiffers J., Witz F., Delannoy A., Dreyfus F., Hervé P., Archimbaud H., Chauvin F., Gratecos N. Adult acute lymphoblastic leukemia (ALL). Early results of a multicenter study. Blood 1991; 78: 381
   Google Scholar
• Boucheix C., David B., Sebban C., Racadot E., Béné M. C., Bernard A., Campos L., Jouault H., Sigaux F., Lepage E., Hervé P., Fière D., for the Group on Therapy for Adult Acute Lymphoblastic Leukemia. Immunophenotype of acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). Blood 1994; 84: 1603–1612
   PubMed Web of Science ®Google Scholar
• Jacob M. C., Favre M., Bensa J. C. Membrane cell permeabilisation with saponin and multiparametric analysis by flow cytometry. Cytometry 1991; 12: 550–558
   PubMedGoogle Scholar
• Pelicci P. G., Knowles D. M., Dalla Favera R. Lymphoid tumors displaying rearrangements of both immunoglobulin and T cell receptor genes. Journal of Experimental Medecine 1985; 162: 1015–1024
   PubMed Web of Science ®Google Scholar
• Boldt D. H., Kopecky K. J., Head D., Gehly G., Radich J. P., Appelbaum F. R. Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group experience. Leukemia 1994; 8: 2118–2126
   PubMed Web of Science ®Google Scholar
• Casasnovas R. O., Solary E., Campos L., Maynadié M., Favre M., Bremend J. L., Garand R., Béné M. C., Faure G., the GEIL. Prognostic relevance of surface markers in adult de novo acute myeloblastic leukemias: a prospective study of the Groupe d'Etude Immunologique des Leucémies (G.E.I.L.). Leukemia and Lymphoma 1994; 13: 7–10
   PubMed Web of Science ®Google Scholar
• Garand R., Vannier J. P., Béné M. C., Faure G. C., Bernard A. Correlation between acute lymphoid leukemia (ALL) immunophenotype and clinical and laboratory data at presentation. Cancer 1989; 64: 1437–1446
   PubMed Web of Science ®Google Scholar
• Ghanem N., Dariavach P., Bensmana M., Chibani J., Lefranc G., Lefranc M. P. Polymorphism of immunoglobulin lambda constant region genes in populations from France, Lebanon and Tunisia. Experimental Clinical Immunogenetics 1988; 5: 186–195
   PubMedGoogle Scholar
• Lenormand B., Ghanem N., Tilly H., Boussemart C., Monconduit M., Piguet H., Lefranc G., Lefranc M. P. Rearrangement of immunoglobulin light and heavy chain genes and correlation with phenotypic markers in B-cell chronic lymphocytic leukemia. Leukemia 1991; 5: 928–936
   PubMed Web of Science ®Google Scholar
• Lefranc M. P., Foster A., Rabbitts T. H. Rearrangement of two distinct T cell γ-chain variable region in human DNA. Nature 1986; 319: 420–422
   PubMed Web of Science ®Google Scholar
• Mengle-Gaw L., Rabitts T. H. A human chromosome 8 region with abnormalities in B cell HTLVI+T cell and C-myc amplified tumors. EMBO Journal 1987; 6: 1959–1965
   PubMed Web of Science ®Google Scholar
• Waldmann T. A., Mark M. D., Davis M. M., Bongiovanni K. F., Korsmeyer S. J. Rearrangements of genes for the antigen receptor on T cells as markers of lineage and clonality in human lymphoid neoplasms. British Journal of Haematology 1985; 313: 776–783
   Google Scholar
• Dariavach P., Lefranc G., Lefranc M. P. Human immunoglobulin Cλ6 gene encodes the Kern+O2-λ chain and Cλ4 and Cλ5 are pseudogenes. Proceedings of the National Academy of Sciences USA 1987; 84: 9074–9078
   PubMed Web of Science ®Google Scholar
• Harnden D. G., Klinger H. P. An international system for human cytogenetic nomenclature, eds ISCN. Karger, BaselSwitzerland 1985
   Google Scholar
• Kaplan E. L., Meier P. Non-parametric estimation from incomplete observations. American Statistics Association Journal 1985; 53: 457–481, Lefranc, M.P., Foster, A. and Rabbitts, T.H. (1986). Rearrangement of two distinct T cell γ-chain variable regions in human DNA. Nature319 420–422
   Google Scholar
• Fink F. M., Köller U., Mayer H., Haas O. A., Grümayer-Panzer E. R., Urban C., Dengg K., Mutz I., Tüchler H., Gatterer-Menz I., Knapp W., Gadner H. Prognostic significance of myeloid-associated antigen expression on blast cells in children with acute lymphoblastic leukemia. Medical and Pediatric Oncology 1993; 21: 340–346
   PubMedGoogle Scholar
• McKinney P. A., Alexander F. E., Cartwright R. A., Scott C. S., Staines A. Acute lymphoblastic leukemia incidence in the UK by immunophenotype. Leukemia 1993; 7: 1630–1634
   PubMed Web of Science ®Google Scholar
• Ludwig W. D., Bartram C. R., Harbott J., Köller U., Haas O. A., Hansen-Hagge T., Heil G., Seibt-Jung H., Teichmann J. V., Ritter J., Knapp W., Gadner H., Thiel E., Riehm H. Phenotypic and genotypic heterogeneity in infant acute leukemia. I. Acute lymphoblastic leukemia. Leukemia 1989; 3: 431–439
   PubMed Web of Science ®Google Scholar
• De Rossi G., Grossi C., Foa R., Tabilio A., Vegna L., Lo Coco F., Annino L., Camera A., Cascavilla N., Ciolli S., Del Poeta G., Liso V., Mandelli F. Immunophenotype of acute lymphoblastic leukemia cells: the experience of the Italian Cooperative Group (Gimema). Leukemia and Lymphoma 1993; 9: 221–228
   PubMed Web of Science ®Google Scholar
• Taskov H., Dimitrova E., Serbinova M., Mendisova L., Bobev D. Immunological subtypes of childhood acute lymphoblastic leukemia in Bulgaria. Leukemia Research 1995; 19: 877–881
   PubMed Web of Science ®Google Scholar
• Pui C. H., Behm F. G., Downing J. R., Hancock M. L., Shurtlell S. A., Ribeiro R. C., Head D. R., Mahmoud H. H., Sandlund J. T., Furman W. L., Roberts W. M., Crist W. M., Raimondi S. C. 11q23/MLL Rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. Journal of Clinical Oncology 1994; 12: 909–915
   PubMed Web of Science ®Google Scholar
• Pui C. H., Ribeiro R. C., Campana D., Raimondi S. C., Hancock M. L., Behm F. G., Sandlund J. T., Rivera G. K., Evans W. E., Crist W. M., Krance R. Prognostic factors in the acute lymphoid and myeloid leukemias of infants. Leukemia 1996; 10: 952–956
   PubMed Web of Science ®Google Scholar
• Hanson C. A., Abaza M., Sheldon S., Ross C. W., Schnitzer B., Stoolman L. M. Acute biphenotypic leukemia: immunophenotypic and cytogenetic analysis. British Journal of Haematology 1993; 84: 49–60
   PubMed Web of Science ®Google Scholar
• Pui C. H., Behm F. G., Crist W. M. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 1993; 82: 334–362
   Google Scholar
• Greil J., Gramatzki M., Burger R., Marschalek R., Peltner M., Trautmann U., Hansen Hagge T. E., Bartram C. R., Fey G. H. The acute lymphoblastic leukemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin-7. British Journal of Haematology 1995; 86: 275–83
   Web of Science ®Google Scholar
• Campos L., Guyotat D., Gentilhomme O., Treille D., Fiere D., Germain D. Expression of a B-lymphoid differentiation antigen (CD 19) on acute non-lymphoblastic leukemia cells. European Journal of Haematology 1987; 38: 220–224
   PubMed Web of Science ®Google Scholar
• Uckun F. M. Regulation of human B-cell ontogeny. Blood 1990; 76: 1908–1923
   PubMed Web of Science ®Google Scholar
• Solary E., Casanovas R. O., Campos L., Béné M. C., Faure G., Maignon P., Falkenrodt A., Lenormand B., Genetet N., The Groupe d'étude Immunologique des Leucemies (GEIL). Surface markers in adult myeloblastic leukemia: correlation of CD 19+, CD34+, and CD14/DR- phenotypes with shorter survival. Leukemia 1992; 6: 393–399
   PubMed Web of Science ®Google Scholar
• Delikat S. E., Galvani D. W., Zuzel M. A function of CD10 on bone marrow stroma. British Journal of Haematology 1994; 87: 655–657
   PubMed Web of Science ®Google Scholar
• Shipp M. A., Look A. T. Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key. Blood 1993; 82: 1052–1070
   PubMed Web of Science ®Google Scholar
• Umiel T., Pattengale P., Weinberg K. Recombination activating gene-1 (RAG-1) expression in all differentiation stages of B-lineage precursor acute lymphoblastic leukemia. Leukemia 1993; 7(3)435–440
   PubMed Web of Science ®Google Scholar